Chicago Trust’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,605
Closed -$204K 391
2025
Q3
$204K Sell
1,605
-1,016
-39% -$121K 0.03% 395
2025
Q2
$321K Buy
2,621
+281
+12% +$32.1K 0.05% 319
2025
Q1
$237K Sell
2,340
-3
-0.1% -$293 0.04% 329
2024
Q4
$216K Buy
2,343
+51
+2% +$5.01K 0.04% 332
2024
Q3
$221K Buy
+2,292
New +$206K 0.04% 347
2022
Q4
Sell
-6,091
Closed -$275K 304
2022
Q3
$275K Sell
6,091
-1,881
-24% -$94.1K 0.07% 235
2022
Q2
$356K Hold
7,972
0.09% 206
2022
Q1
$451K Buy
7,972
+3,021
+61% +$158K 0.1% 199
2021
Q4
$257K Sell
4,951
-2,406
-33% -$124K 0.05% 288
2021
Q3
$439K Buy
7,357
+3,356
+84% +$211K 0.1% 208
2021
Q2
$249K Buy
+4,001
New +$267K 0.06% 272

Other funds holding EHC

Chicago Trust's EHC Position: Q4 2025 in Review

Chicago Trust sold out of Encompass Health (EHC) in Q4 2025, closing a stake of 1,605 shares — an estimated $204K sold.

Chicago Trust first reported a position in EHC in Q2 2021 and held it in 11 quarters. The position peaked at $451K in Q1 2022. 594 funds tracked by Wall St. Rank hold EHC as of Q4 2025.

  • Chicago Trust reported no remaining Encompass Health position as of Q4 2025 after selling out during the quarter.
  • Chicago Trust sold 1,605 Encompass Health shares in Q4 2025, an estimated $204K.
  • Chicago Trust first reported a position in Encompass Health in Q2 2021 and held it in 11 quarters.
  • Chicago Trust's Encompass Health position peaked at $451K in Q1 2022.
  • 594 funds tracked by Wall St. Rank held Encompass Health as of Q4 2025.

Based on Chicago Trust's 13F filing for Q4 2025, filed 17 Feb 2026.